AUNA (AUNA) Q3 2024: Mexico EBITDA Margin Jumps 4.7 Points as Platform Integration Accelerates

November 20, 2024 | By EarningsIQ Research

AUNA’s Q3 marked a turning point in Mexico, with EBITDA margin surging on physician productivity and high-complexity services. Peru’s mature model continued to outperform, while Colombia’s short-term profitability was impacted by conservative provisioning amid payer uncertainty. Management reaffirmed full-year guidance, citing robust platform integration and cash flow discipline as levers for continued regional expansion.

Summary

• Margin Expansion in Mexico: Physician recruiting and high-complexity services drove a step-change in profitability.
• Peru’s Model Validated: Mature integration delivered outsized margin and cash flow, reinforcing scalability.
• Colombia Risk Managed: Conservative provisioning protects cash, but underscores ongoing payer volatility.

Business Overview

AUNA is a vertically and horizontally integrated healthcare platform operating in Peru, Mexico, and Colombia. The company generates revenue from healthcare services, insurance plans, and oncology solutions, with major segments by geography: Peru (mature, integrated), Mexico (growth and integration focus), and Colombia (scale, but currently risk-managed). Its business model centers on growing plan memberships, optimizing service mix toward high-complexity procedures, and leveraging regional scale for operational efficiency.

Performance Analysis

Q3 results highlighted the earnings leverage of AUNA’s platform integration, especially in Mexico and Peru. Mexico’s healthcare services delivered a 16% revenue increase and a 34% adjusted EBITDA gain, with margin expanding 4.7 percentage points to nearly 36%. This was fueled by physician productivity programs and a shift toward more profitable, high-complexity care. Peru, the company’s most mature market, posted a 13% revenue rise and nearly 50% EBITDA growth, with margin up 5.3 points to 21.6%, reflecting membership growth and optimized specialty allocation.

Colombia’s segment remained strategically important but saw near-term profitability pressured by elevated provisions for receivables. While occupancy and procedure mix improved, the need for increased impairment reserves—tied to payer volatility and regulatory intervention—drove an 18% decline in adjusted EBITDA and a 4.5-point margin contraction. Excluding these provisions, underlying profitability would have grown, but management prioritized cash cycle discipline over growth.

• Mexico Margin Inflection: Physician loyalty programs and bundled service sales materially lifted margin and revenue quality.
• Peru’s Maturity Play: Plan membership and high-complexity care remain core profit drivers, validating the integrated model.
• Colombia Provisioning: Conservative accounting for payer risk weighed on profit, but protected cash flow and balance sheet integrity.

Cash generation improved across the platform, with leverage dropping below four times EBITDA for the first time since the Mexico acquisitions, supporting both growth investments and debt reduction aims.

Executive Commentary

Strategic Positioning

1. Mexico: Physician Productivity and High-Complexity Services Drive Margin Upside

Mexico’s rapid EBITDA margin expansion reflects deliberate investments in physician recruitment, loyalty programs, and bundled service sales (Plan Libertad, bundled product offering). Management cited a near doubling of enrolled physicians in its loyalty program, directly boosting procedure volume and revenue mix. The launch of OncoMexico, an integrated oncology insurance offering, is positioned as a disruptive entry into an underpenetrated market, with a pilot phase targeting B2B first and B2C to follow.

2. Peru: Mature Platform Demonstrates Scalability and Profitability

Peru remains the proof-of-concept for AUNA’s integrated model. Membership growth and a strategic shift toward higher-complexity procedures enabled margin expansion and strong cash flow. Management expects these profitability levels to persist, citing continued opportunity in member base growth and service mix optimization.

3. Colombia: Cautious Growth, Cash Flow Focus Amid Regulatory Uncertainty

Colombia’s contribution is being carefully managed due to payer instability and regulator interventions (notably with Nueva EPS). The company increased provisions for receivables, prioritized collections, and dialed back growth to protect cash flow. Management maintains a constructive medium-term outlook, viewing current challenges as transitory but remaining vigilant on working capital and payer relationships.

4. Leverage Reduction and Capital Allocation Discipline

EBITDA growth and cash flow generation enabled leverage to fall below four times, with management reiterating a target of under three times in the medium term. Organic free cash flow now covers interest, setting up for future debt amortization and potential asset sales if needed, though current cash generation is expected to drive further deleveraging.

5. Platform Replication and Innovation

AUNA’s strategy is to replicate its Peru playbook in larger, less penetrated markets like Mexico, while selectively innovating with new insurance offerings (OncoMexico) and digital tools. The company continues to invest in SAP implementation and network synergies to support scalable, region-wide operations.

Key Considerations

This quarter’s results reinforce AUNA’s thesis that platform integration and high-complexity care drive sustainable profit growth, but also highlight the need for disciplined risk management in less stable markets like Colombia.

Key Considerations:

• Mexico Margin Sustainability: Whether recent physician productivity gains and bundled sales can be sustained as the platform scales.
• Peru as Margin Benchmark: The durability of Peru’s high margin as a template for other markets, particularly as competition intensifies.
• Colombia Receivables Risk: The extent and duration of payer volatility, and the impact on cash flow and growth pacing.
• Leverage Trajectory: The ability to reach sub-three times leverage organically, or if asset sales or refinancing will be required.
• OncoMexico Commercialization: The pace of B2B and eventual B2C uptake, and its effect on revenue mix and margin in Mexico.

Risks

AUNA faces material risks from regulatory and payer instability in Colombia, which could further impact receivables and near-term profitability. There is also execution risk in scaling the Mexico platform and commercializing new insurance products. Macro factors such as FX volatility, healthcare reform, and competitive responses in private healthcare markets remain ongoing watchpoints, particularly as the company balances growth with cash flow discipline.

Forward Outlook

For Q4 2024, AUNA guided to:

• Maintaining current adjusted EBITDA growth trajectory (20% FX-neutral guidance reaffirmed)
• Continued margin expansion in Mexico and Peru, with cash flow focus in Colombia

For full-year 2024, management maintained guidance:

• Adjusted EBITDA growth of 20% FX-neutral

Management highlighted several factors that will shape upcoming quarters:

• Continued physician recruitment and high-complexity service mix in Mexico
• Disciplined working capital and provisioning in Colombia to protect cash cycle

Takeaways

The quarter underscores AUNA’s ability to scale its integrated healthcare model in new markets, while managing risk and maintaining financial discipline.

• Mexico Margin Inflection: Physician programs and bundled sales are driving rapid margin gains, but sustainability will be tested as scale increases.
• Peru Sets the Bar: The mature model’s profitability and cash flow provide a template and funding for regional expansion.
• Colombia Remains a Swing Factor: Receivables and regulatory risk will continue to dictate the pace and quality of growth in this segment.

Conclusion

AUNA’s Q3 demonstrated the earnings power of platform integration, especially in Mexico and Peru, while Colombia’s risk management approach protected cash at the expense of near-term profit. The company’s reaffirmed guidance and ongoing leverage reduction position it well for continued expansion, but execution and payer risk remain critical watchpoints for investors.

Industry Read-Through

AUNA’s results reinforce the strategic value of integrated healthcare platforms in Latin America, especially in markets where private care is underpenetrated but demand is rising. The success of physician productivity programs and bundled service offerings in Mexico may prompt competitors to accelerate similar initiatives. Colombia’s regulatory and payer volatility is a cautionary signal for peers operating in similar environments, highlighting the importance of conservative provisioning and cash management. The gradual rollout of innovative insurance products like OncoMexico signals growing appetite for specialized, preventive coverage in the region, which could reshape the competitive landscape for both providers and insurers.

AUNA Healthcare Integrated Care Latin America Margin Expansion Platform Integration Insurance Physician Productivity